CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The study will evaluate the safety and performance of Symphony™ versus Standard of Care (SOC) in the treatment of chronic non-healing diabetic...
Gastonia, North Carolina, United States and 10 other locations
(Dehydrated Human Placental Tissue) Product and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic...
Phase 4
Mooresville, North Carolina, United States and 7 other locations
The goal of this clinical trial is to learn if using perinatal tissue allografts improves healing of chronic, non-healing foot ulcers in diabetic...
Monroe, North Carolina, United States of America
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Charlotte, North Carolina, United States of America and 182 other locations
This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...
Phase 2
Statesville, North Carolina, United States and 54 other locations
double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...
Phase 2
Statesville, North Carolina, United States and 96 other locations
Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Ma...
Phase 3
Charlotte, North Carolina, United States and 75 other locations
study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes...
Phase 2
Charlotte, North Carolina, United States and 48 other locations
control in participants with obesity or with overweight and type 2 diabetes. This trial is part of the master protocol study J2A-MC-GZPO.Par...
Phase 3
Charlotte, North Carolina, United States and 88 other locations
participants who have obesity or overweight with or without type 2 diabetes. Participants will be screened for about 4 weeks, after which th...
Phase 3
Charlotte, North Carolina, United States and 88 other locations
Clinical trials
Research sites
Resources
Legal